We believe that it is important to use this synoptic PALGA protocol to monitor and benchmark the major pathology breast cancer biomarkers, namely ER, PR, HER2 and histologic grade, as these are crucial in decision making in current clinical practice [1]. The gene discussed is ERBB2; the disease is breast cancer.